Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Cell Therapy Market: By Type: Autologous, Allogeneic; By Therapy: Mesenchymal Stem Cell Therapy, Fibroblast Cell Therapy, Haematopoietic Stem Cell Therapy; By Application; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Value Chain Analysis; Competitive Landscape; Industry Events and Developments
Global Cell Therapy Market Outlook
The global cell therapy market is expected to grow in the forecast period of 2023-2028 at a CAGR of 7%.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Use of Cell Therapies to Treat Severe COVID-19 Patients to Boost the Growth of the Cell Therapy Industry
The global market for cell therapy is being driven by the increasing research and development (R&D) activities in the medical industry. Cell therapy is increasingly being used to treat patients with cancer, weakened immune systems, infectious diseases, and neurological disorders, which, in turn, surging its demand. Further, the COVID-19 pandemic is expected to positively impact the pharmaceutical and biotechnology-based research projects, including cell therapy. As the SARS-CoV-2 virus critically damages the lungs and immune system of the infected patient, various cell therapies are increasingly being explored as a potential treatment for the novel disease. Moreover, cell therapy can substantially improve survival rates of end-stage patients with acute respiratory distress syndrome (ARSD) associated with SARS-CoV-2, which is providing further impetus to the industry growth.
Europe Represents a Significant Regional Market for Cell Therapy Due to the Rising R&D Activities
Europe holds a significant share of the overall cell therapy industry, with France and the United Kingdom being some of the dominant regional markets. The increasing research and development activities in France, owing to the presence of some of the leading biotech and research institutions of cell therapy, are aiding the market growth. In addition, the French biotech institutions, with government aid, are contributing to the development of innovative cell therapies. Moreover, the introduction of various favourable government initiatives to aid research activities is invigorating the industry growth, hence contributing to the overall market growth in the European region. For instance, the United Kingdom government initiated the Human-Induced Pluripotent Stem Cells Initiative (HipSCi) to bring preclinical, clinical and pharmacological work on stem cells under one institution and increase the accessibility of induced pluripotent stem cell (iPSC) resources to identify new mechanisms.
Cell Therapy: Industry Definition and Segmentation
Cell therapy refers to a medical treatment in which ailing or dysfunctional cells are replaced with healthy and functional cells. The therapy aims at reducing or curing symptoms of diseases by restoring and altering certain sets of cells or by using cells to carry a remedy through the body. These cells may either be derived from the patient (autologous cells) or a donor (allogeneic cells). The cells are cultivated outside the body before transplanting into the patient.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on type, the market is divided into:
- Autologous
- Allogeneic
On the basis of therapy, the cell therapy industry is categorised into:
- Mesenchymal Stem Cell Therapy
- Fibroblast Cell Therapy
- Haematopoietic Stem Cell Therapy
Based on application, the market is segmented into:
- Musculoskeletal
- Malignancies
- Cardiovascular
- Dermatology and Wounds
The EMR report looks into the regional market of cell therapy like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Investments in Infrastructure and Technology of Cell Therapy to Augment the Market Growth
With the growth in discoveries and innovations taking place around the globe, the healthcare sector is flourishing rapidly, which, in turn, is aiding the growth of the cell therapy industry. Cell therapies are becoming an ideal choice for treatment due to their high success rate, which is expected to fuel the market growth further. Various innovative cell therapies are emerging as a promising treatment for cancer and other diseases and are supporting the overall market growth. Increasing investments in the field of cell therapy, growing technological advancements, and rising cases of diseases such as cancer and cardiac abnormalities are also driving the growth of the industry.
The rapid expansion of the cell therapy industry to enhance the accessibility and functionality of cell therapies while reducing toxicity is anticipated to propel the market growth. The development of effective treatment of solid tumours is likely to be another breakthrough for cell-based therapies, which is expected to positively impact the market development in the coming years. Furthermore, the increasing investments for the research and development (R&D) activities to minimise costs during the manufacturing process while eliminating the requirement of a specialised structure is estimated to invigorate the growth of the cell therapy industry. The potential for cell therapy to treat major diseases such as cancer, anaemia, and Alzheimer’s disease, among others, is projected to further strengthen the cell therapy industry in the forecast period.
Key Industry Players in the Global Cell Therapy Market
The report presents a detailed analysis of the following key players in the global cell therapy market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions.
- Tego Science
- Chiesi Farmaceutici S.p.A
- Pharmicell Co., Ltd
- Others
The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, Therapy, Application, Region |
| Breakup by Type | Autologous, Allogeneic |
| Breakup by Therapy | Mesenchymal Stem Cell Therapy, Fibroblast Cell Therapy, Haematopoietic Stem Cell Therapy |
| Breakup by Application | Musculoskeletal, Malignancies, Cardiovascular, Dermatology and Wounds |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Tego Science, Chiesi Farmaceutici S.p.A., Pharmicell Co., Ltd., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Cell Therapy Market Analysis
8.1 Key Industry Highlights
8.2 Global Cell Therapy Historical Market (2018-2022)
8.3 Global Cell Therapy Market Forecast (2023-2028)
8.4 Global Cell Therapy Market by Type
8.4.1 Autologous
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Allogeneic
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.5 Global Cell Therapy Market by Therapy
8.5.1 Mesenchymal Stem Cell Therapy
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Fibroblast Cell Therapy
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Haematopoietic Stem Cell Therapy
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2018-2022)
8.5.3.3 Forecast Trend (2023-2028)
8.6 Global Cell Therapy Market by Application
8.6.1 Musculoskeletal
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Malignancies
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Cardiovascular
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Dermatology and Wounds
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2022)
8.6.4.3 Forecast Trend (2023-2028)
8.7 Global Cell Therapy Market by Region
8.7.1 North America
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Europe
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Asia Pacific
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Latin America
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2022)
8.7.4.3 Forecast Trend (2023-2028)
8.7.5 Middle East and Africa
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2018-2022)
8.7.5.3 Forecast Trend (2023-2028)
9 North America Cell Therapy Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Cell Therapy Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Cell Therapy Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Cell Therapy Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Cell Therapy Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Tego Science
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Chiesi Farmaceutici S.p.A.
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Pharmicell Co., Ltd.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Cell Therapy Market: Key Industry Highlights, 2018 and 2028
2. Global Cell Therapy Historical Market: Breakup by Type (USD Million), 2018-2022
3. Global Cell Therapy Market Forecast: Breakup by Type (USD Million), 2023-2028
4. Global Cell Therapy Historical Market: Breakup by Therapy (USD Million), 2018-2022
5. Global Cell Therapy Market Forecast: Breakup by Therapy (USD Million), 2023-2028
6. Global Cell Therapy Historical Market: Breakup by Application (USD Million), 2018-2022
7. Global Cell Therapy Market Forecast: Breakup by Application (USD Million), 2023-2028
8. Global Cell Therapy Historical Market: Breakup by Region (USD Million), 2018-2022
9. Global Cell Therapy Market Forecast: Breakup by Region (USD Million), 2023-2028
10. North America Cell Therapy Historical Market: Breakup by Country (USD Million), 2018-2022
11. North America Cell Therapy Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Europe Cell Therapy Historical Market: Breakup by Country (USD Million), 2018-2022
13. Europe Cell Therapy Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Asia Pacific Cell Therapy Historical Market: Breakup by Country (USD Million), 2018-2022
15. Asia Pacific Cell Therapy Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Latin America Cell Therapy Historical Market: Breakup by Country (USD Million), 2018-2022
17. Latin America Cell Therapy Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Middle East and Africa Cell Therapy Historical Market: Breakup by Country (USD Million), 2018-2022
19. Middle East and Africa Cell Therapy Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Global Cell Therapy Market Structure
Key Questions Answered in the Report
The global cell therapy market is projected to grow at a CAGR of 7% between 2021 and 2026.
The cell therapy industry is being aided by the introduction of various favourable government initiatives and the rising investment in the healthcare sector for the integration of technological advancements in biotechnological researches.
The industry is anticipated to be driven by the use of cell therapies as effective COVID-19 and cancer treatments, the rising cost-effectiveness of cell therapy, and the increasing investments in research and development (R&D) activities.
The major regions in the industry are North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
The major types of cell therapy in the market are autologous and allogeneic.
Mesenchymal stem cell therapy, fibroblast cell therapy, and hematopoietic stem cell therapy are the leading therapy segments in the cell therapy industry.
The significant application segments of cell therapy in the market are musculoskeletal, malignancies, cardiovascular, and dermatology and wounds.
They key players in the market are Tego Science, Chiesi Farmaceutici S.p.A, and Pharmicell Co., Ltd, among others.
Analyst Review
The global cell therapy market was driven by the rising use of cell therapy in the treatment of critical COVID-19 patients. Aided by the increasing investments into the development of cell therapies, the market is expected to witness a healthy growth in the forecast period of 2023-2028 growing at a CAGR of 7%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its type, cell therapy is divided into autologous and allogeneic. On the basis of therapy, the market is segmented into mesenchymal stem cell therapy, fibroblast cell therapy, and hematopoietic stem cell therapy. Based on its application, the market is categorised into musculoskeletal, malignancies, cardiovascular, and dermatology and wounds. The major regional markets for cell therapy are North America, Latin America, Europe, the Asia Pacific, and the Middle East and Africa. The key players in the above market include Tego Science, Chiesi Farmaceutici S.p.A, and Pharmicell Co., Ltd, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER